Cargando...

Lapatinib – Member of a New Generation of ErbB-Targeting Drugs

SUMMARY: Women with advanced or metastatic ErbB2 (HER2)-positive breast cancer have limited therapeutic options once their disease has progressed on trastuzumab-based standard initial chemotherapy regimens. Therefore, there has been a clear need for alternative treatments in this advanced setting. T...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Untch, Michael, Lück, Hans-Joachim
Formato: Artigo
Lenguaje:Inglês
Publicado: S. Karger GmbH 2010
Materias:
Acceso en línea:https://ncbi.nlm.nih.gov/pmc/articles/PMC2931094/
https://ncbi.nlm.nih.gov/pubmed/20847830
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1159/000285750
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!